Drugs / Rota-V-Aid™
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05037435 | Jun → Jul 2018 | Rotavirus infection | Limited Liability Company Pharm Aid | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rota-V-Aid | “The purpose of the presented study was to evaluate the safety and immunological efficacy in preventing the rotavirus infection within a cohort of healthy subjects (target age...” NCT05037435 ↗ |
| Modality | Vaccine | “the pentavalent rotavirus vaccine - Rota-V-Aid™ (live attenuated oral, freeze-dried)” NCT05037435 ↗ |
| Route | Oral | “Single-use orally 2.5 ml (1 dose).” NCT05037435 ↗ |